New insight into strategies used to develop long-acting G-CSF biologics for neutropenia therapy

Overview of attention for article published in Frontiers in oncology, January 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

So far, Altmetric has seen 86 X posts from 62 X users, with an upper bound of 277,994 followers.

@jlberrymd @Kishokai1 @OncBrothers Not a physician but my reading showed eflapegrastim performing better than pegfilgrastim on many metrics hence the question. Here are the references: 1. https://t.co/shgmgXVdjb 2. https://t.co/iw1jA3GCS2 3. https://t.co

RT @waha_52: 📍#ورقة_علمية لطريقة كتابة الريفيو Article Review مفيدة جداً. 👇🏼 #البحث_العلمي #الدراسات_العليا https://t.co/BqFmYXth8e ht…

📍#ورقة_علمية لطريقة كتابة الريفيو Article Review مفيدة جداً. 👇🏼 #البحث_العلمي #الدراسات_العليا https://t.co/BqFmYXth8e https://t.co/gO4tkzTyML

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 82 additional X posts.